Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.64
28.03.24
-
28.03.25
-40.27%
31.03.24

Risky Investment
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.55
28.03.24
-
28.03.25
-38.27%
30.03.24

Could be worthwhile Investment >10% per year
buy
Deutsche Pfandbriefbank AG

Start price
Target price
Perf. (%)
€4.81
27.03.24
€5.00
27.03.25
5.24%
09.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.88
26.03.24
-
26.03.25
-18.09%
31.03.24

Risky Investment
buy
Hypoport SE

Start price
Target price
Perf. (%)
€239.60
22.03.24
-
22.03.25
13.11%
06.05.24

Very low/no dividend yield expected
EBIT decline/stagnation expected
buy
SMA Solar Technology AG

Start price
Target price
Perf. (%)
€55.00
22.03.24
-
22.04.24
-13.27%
23.04.24

Could be worthwhile Investment >10% per year
buy
Medigene AG

Start price
Target price
Perf. (%)
€2.69
22.03.24
-
22.03.25
-16.73%
30.03.24

Could be very worthwhile Investment >20% year
Very capable Management
Good culture
Little innovation
SynBiotic SE

Start price
Target price
Perf. (%)
€13.65
22.03.24
-
22.03.25
-6.59%
30.03.24

Probably not worthwhile Investment
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.57
21.03.24
-
21.03.25
-38.64%
31.03.24

Could be very worthwhile Investment >20% year
buy
Sfc Energy AG

Start price
Target price
Perf. (%)
€17.90
21.03.24
-
21.04.24
2.35%
22.04.24

Could be worthwhile Investment >10% per year
Nel ASA

Start price
Target price
Perf. (%)
€0.41
21.03.24
-
21.03.25
10.89%
14.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Nel ASA

Start price
Target price
Perf. (%)
€0.48
21.03.24
-
-
21.03.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Northern Data AG

Start price
Target price
Perf. (%)
€26.70
20.03.24
-
20.03.25
-17.60%
15.06.24

High dividend yield expected
positive Cash Flow expected
Normal challenges to pay loans and raise capital
Higher risks for its business
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€16.94
19.03.24
€22.00
19.03.25
14.24%
30.03.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Some uniques
Risky balance sheet
buy
Super Micro Computer

Start price
Target price
Perf. (%)
€828.60
19.03.24
€900.00
19.03.25
18.14%
30.03.24

Could be very worthwhile Investment >20% year
Higher EBIT margin than peer group
Capable Management
Low dividend yield expected
buy
Enveric Biosciences Inc.

Start price
Target price
Perf. (%)
€1.39
19.03.24
-
19.03.25
-41.25%
30.03.24

Could be very worthwhile Investment >20% year
Very good company culture
Very capable Management
Few uniques
buy
Silvercorp Metals Inc.

Start price
Target price
Perf. (%)
€2.59
18.03.24
-
18.03.25
24.09%
30.03.24

Could be worthwhile Investment >10% per year
Capable Management
Revenue growth >5% per year expected
positive Cash Flow expected
Super Micro Computer

Start price
Target price
Perf. (%)
€973.00
18.03.24
€666.00
18.03.25
0.61%
30.03.24

Probably not worthwhile Investment
High valuation
Low dividend yield expected
negative Cash Flow expected
buy
Hochschild Mining plc

Start price
Target price
Perf. (%)
€1.35
18.03.24
€366.00
18.03.25
15.30%
30.03.24

Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Fair valuation
EBIT growth >5% per year expected
buy
ABC Arbitrage S.A.

Start price
Target price
Perf. (%)
€3.85
18.03.24
-
18.03.25
2.47%
30.03.24

Could be worthwhile Investment >10% per year
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
18.03.24
-
18.03.25
2.26%
30.03.24

Could be worthwhile Investment >10% per year
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
17.03.24
€0.30
30.11.25
76.96%
28.03.24

Could be very worthwhile Investment >20% year
buy
Inventiva SA

Start price
Target price
Perf. (%)
€3.71
17.03.24
€5.00
31.01.26
-2.70%
19.03.24

Could be very worthwhile Investment >20% year
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€10.20
17.03.24
€16.00
30.06.26
-8.82%
19.03.24

Could be very worthwhile Investment >20% year
buy
PNE AG

Start price
Target price
Perf. (%)
€13.94
16.03.24
€20.00
16.04.24
-5.02%
17.04.24

Could be worthwhile Investment >10% per year